MyFinsight
Home
Blog
About
Back
Income Statement
GT Biopharma, Inc. (GTBP)
GT Biopharma, Inc. (GTBP)
source: myfinsight.com
Net loss
attributable to common...
-$4,592K
(-202.50%↓ Y/Y)
Net loss
-$4,518K
(-215.28%↓ Y/Y)
Dividend on preferred
stock
$74K
Loss from operations
-$4,512K
(-198.22%↓ Y/Y)
Total other income
(expense), net
-$6K
(-107.50%↓ Y/Y)
Interest income
$58K
(52.63%↑ Y/Y)
Selling, general and
administrative
$3,457K
(200.61%↑ Y/Y)
Research and development
$1,055K
(190.63%↑ Y/Y)
Interest expense
$64K
Back